Novo Nordisk A/S (NOV.DE)
EUR 58.1
(1.25%)
EUR 58.1
(1.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 232.26 Billion | 23.72 Billion | 18.93 Billion | 17.05 Billion | 16.32 Billion | 14.98 Billion |
| Cost of Revenue | 35.76 Billion | 4.15 Billion | 3.4 Billion | 3.1 Billion | 2.83 Billion | 2.53 Billion |
| Gross Profit | 196.49 Billion | 19.57 Billion | 15.53 Billion | 13.94 Billion | 13.49 Billion | 12.45 Billion |
| Operating Expenses | 93.92 Billion | 9.59 Billion | 7.59 Billion | 6.67 Billion | 6.39 Billion | 6.26 Billion |
| Selling, General and Administrative Expenses | 61.59 Billion | 6.67 Billion | 5.4 Billion | 4.83 Billion | 4.66 Billion | 4.44 Billion |
| Research and Development Expenses | 32.44 Billion | 2.91 Billion | 2.19 Billion | 1.84 Billion | 1.72 Billion | 1.81 Billion |
| Other Expenses | -119 Million | - | - | - | - | - |
| Cost and Expenses | 129.68 Billion | 13.74 Billion | 10.99 Billion | 9.78 Billion | 9.22 Billion | 8.79 Billion |
| Operating Income | 102.57 Billion | 9.97 Billion | 7.93 Billion | 7.27 Billion | 7.1 Billion | 6.19 Billion |
| Interest Expense | 739 Million | 378 Million | 289 Million | 390 Million | 67.04 Million | 21.03 Million |
| Income Tax Expense | 20.99 Billion | 1.81 Billion | 1.52 Billion | 1.47 Billion | 1.28 Billion | 1.2 Billion |
| Earnings before Tax | 104.67 Billion | 9.28 Billion | 7.94 Billion | 7.11 Billion | 6.51 Billion | 6.37 Billion |
| Net Income | 83.68 Billion | 7.44 Billion | 6.42 Billion | 5.66 Billion | 5.21 Billion | 5.17 Billion |
| Earnings Per Share Basic | 18.67 | 1.64 | 1.40 | 1.21 | 1.10 | 1.07 |
| Earnings Per Share Diluted | 18.62 | 1.64 | 1.39 | 1.21 | 1.10 | 1.07 |
| Weighted Average Shares Outstanding | 4.48 Billion | 4.53 Billion | 4.59 Billion | 4.66 Billion | 4.74 Billion | 4.83 Billion |
| Weighted Average Shares Outstanding (Diluted) | 4.49 Billion | 4.54 Billion | 4.6 Billion | 4.68 Billion | 4.75 Billion | 4.84 Billion |
| Gross Margin | 0.85 | 0.82 | 0.82 | 0.82 | 0.83 | 0.83 |
| EBIT Margin | 0.49 | 0.46 | 0.46 | 0.47 | 0.47 | 0.45 |
| Profit Margin | 0.36 | 0.31 | 0.34 | 0.33 | 0.32 | 0.35 |
| EBITDA | 114.62 Billion | 76.8 Billion | 65.39 Billion | 59.27 Billion | 54.43 Billion | 51.62 Billion |
| Earnings Before Tax Margin | 0.44 | 0.42 | 0.42 | 0.43 | 0.43 | 0.41 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 68.06 Billion | 8.73 Billion | 31.14 Billion | 8.83 Billion | 7.85 Billion | 7.27 Billion |
| Cost of Revenue | 10.27 Billion | 1.32 Billion | 5.2 Billion | 1.34 Billion | 1.29 Billion | 1.05 Billion |
| Gross Profit | 57.78 Billion | 7.41 Billion | 25.94 Billion | 7.48 Billion | 6.55 Billion | 6.22 Billion |
| Operating Expenses | 31.85 Billion | 3.07 Billion | 12.07 Billion | 3.9 Billion | 2.96 Billion | 3.01 Billion |
| Selling, General and Administrative Expenses | 16.09 Billion | 1.92 Billion | - | 2.49 Billion | 1.88 Billion | 2.06 Billion |
| Research and Development Expenses | 16.16 Billion | 1.15 Billion | - | 1.4 Billion | 1.08 Billion | 954.63 Million |
| Other Expenses | -405 Million | - | - | - | - | - |
| Cost and Expenses | 42.12 Billion | 4.4 Billion | 17.28 Billion | 5.24 Billion | 4.26 Billion | 4.07 Billion |
| Operating Income | 25.93 Billion | 4.33 Billion | 13.86 Billion | 3.58 Billion | 3.58 Billion | 3.2 Billion |
| Interest Expense | 1.56 Billion | 2.07 Billion | 542 Million | -2.1 Billion | 2.16 Billion | 281 Million |
| Income Tax Expense | 5.28 Billion | 870.74 Million | 2.81 Billion | 758.66 Million | 747.06 Million | 646.42 Million |
| Earnings before Tax | 25.33 Billion | 4.26 Billion | 14.02 Billion | 3.7 Billion | 3.75 Billion | 3.24 Billion |
| Net Income | 20.05 Billion | 3.39 Billion | 11.22 Billion | 2.94 Billion | 3 Billion | 2.6 Billion |
| Earnings Per Share Basic | 0.60 | 0.76 | - | 0.66 | 0.67 | 0.58 |
| Earnings Per Share Diluted | 0.60 | 0.76 | - | 0.66 | 0.67 | 0.58 |
| Weighted Average Shares Outstanding | 4.45 Billion | 4.45 Billion | 4.48 Billion | 4.46 Billion | 4.47 Billion | 4.49 Billion |
| Weighted Average Shares Outstanding (Diluted) | 4.46 Billion | 4.47 Billion | 4.49 Billion | 4.47 Billion | 4.48 Billion | 4.5 Billion |
| Gross Margin | 0.85 | 0.85 | 0.83 | 0.85 | 0.83 | 0.86 |
| EBIT Margin | 0.53 | 0.54 | - | 0.45 | 0.50 | 0.48 |
| Profit Margin | 0.29 | 0.39 | 0.36 | 0.33 | 0.38 | 0.36 |
| EBITDA | 35.73 Billion | 4.72 Billion | - | 3.99 Billion | 3.92 Billion | 3.49 Billion |
| Earnings Before Tax Margin | 0.38 | 0.50 | 0.45 | 0.41 | 0.46 | 0.44 |
ITB
RNMBY
VVU
002355
BCY
002568